应用锥形束CT诊断颞下颌关节骨关节病的探讨

目的探讨锥形束CT（cone beam CT，CBCT）在颞下颌关节骨关节病诊断中的应用前景。方法临床诊断为颞下颌关节骨关节病（炎）、不可复（可复）性盘前移位伴骨关节病患者共48例（96侧关节）。48例同时拍摄经咽侧位x线平片和CBCT，比较两种x线检查方法的病变检出率、医师判断的重复性和一致性。结果颞下颌关节骨关节病x线表现分为6型：髁突表面皮质骨模糊消失型（I型）、表面缺损破坏型（Ⅱ型）、髁突磨平型（Ⅲ型）、骨质硬化型（IV型）、骨质增生型（V型）、囊样变型（Ⅵ型）。CBCT的检出率分别为65．63％、37．50％、27．08％、31．25％、28．13％、1．04％；经咽侧位x线平片的检出率分别为52．08％、19．79％、32．29％、23．96％、12．50％、2．08％。对每一型病变的程度和范围，同一医师两次判断或不同医师之间，对I、Ⅱ型病变的评判，经咽侧位x线平片和CBCT均有高度的一致性，Kappa值大于0．60。结论除Ⅲ型外，CBCT对每一类型的病变均有很高的检出率，所显示的病变及其部位清晰、明确。CBCT清晰的病变影像、明确的病变部位和显示多层面病变的优势，使其有望成为颞下颌关节骨关节病判定病变程度、预后以及药物治疗后效果的定量评价手段。

Cone beam computed tomography in the diagnosis of temporomandibular joint osteoarthrosis

OBJECTIVE: To evaluate the clinical use of cone beam dental CT in the diagnosis of temporomandibular joint osteoarthrosis. METHODS: Forty-eight cases diagnosed as temporomandibular joint osteoarthrosis (OA) and disk displacement with or without reduction accompanied by OA changes were included, and a total of 96 joints received both transpharyngeal radiography and cone beam CT (CBCT) examination. The detectable rate for OA radiographic changes was compared between the two examinations. RESULTS: The radiographic appearances of osteoarthrotic condyle included six types: loss of the lamina dura density of condyle surface (type I), destructive and erosive bone changes (type II), flattening of the articular surface (type III), sclerosis (type IV), osteophytes (type V), and false cyst change (type VI). The detectable ratio of CBCT for all types of osteoarthrosis was 65.63%, 37.50%, 27.08%, 31.25%, 28.13%, 1.04%, respectively, and the detectable ratio of transpharyngeal radiographs was 52.08%, 19.79%, 32.29%, 23.96%, 12.50%, 2.08% respectively. Intraobserver and interobserver reproducibility for type I and type II was in good agreement with both the transpharyngeal radiographs and CBCT, Kappa > 0.60. CONCLUSIONS: CBCT had higher detectable rates for pathological changes of osteoarthrosis, and could show the exact location, size, and the types of pathological changes. CBCT may be used as a measure in evaluating disease severity and progression, and in clinical trials of disease treatment.